The use of indwelling pleural catheters for the treatment of malignant pleural effusions

References

• Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000 Nov;162(5):1987–2001.
   PubMed Web of Science ®Google Scholar
• Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: british Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010 Aug;65(Suppl 2):ii32–ii40.
   PubMed Web of Science ®Google Scholar
• Lui MM, Fitzgerald DB, Lee YC. Phenotyping malignant pleural effusions. Curr Opin Pulm Med. 2016 Jul;22(4):350–355.
   PubMed Web of Science ®Google Scholar
• Rahman NM, Pepperell J, Rehal S, et al. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial. JAMA. 2015;314(24):2641–2653.
   PubMed Web of Science ®Google Scholar
• Dresler CM, Olak J, Herndon JE 2nd, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005 Mar;127(3):909–915.
   PubMed Web of Science ®Google Scholar
• Thomas R, Fysh ET, Smith NA, et al. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial. JAMA. 2017;318(19):1903–1912.
   PubMed Web of Science ®Google Scholar
• Clive AO, Jones HE, Bhatnagar R, et al. Interventions for the management of malignant pleural effusions: a network meta‐analysis. Cochrane Lib. 2016(5).
   Google Scholar
• Van Meter ME, McKee KY, Kohlwes RJ. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med. 2011 Jan;26(1):70–76.
   PubMed Web of Science ®Google Scholar
• Gilbert CR, Feller-Kopman DJCPR. Adjunct strategies to enhance the efficacy of indwelling pleural catheters. Current Pulmonology Reports. 2015;4(1):28–33.
   Google Scholar
• Argento AC, Schembri F. The evolving role of the indwelling tunneled pleural catheter. A means to an end. Am Thorac Soc. 2017 April 15;195(8):976-978
   Google Scholar
• Warren WH, Kalimi R, Khodadadian LM, et al. Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg. 2008 Mar;85(3):1049–1055.
   PubMed Web of Science ®Google Scholar
• Fysh ET, Tremblay A, Feller-Kopman D, et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest. 2013 Nov;144(5):1597–1602.
   PubMed Web of Science ®Google Scholar
• Lui MM, Thomas R, Lee YC. Complications of indwelling pleural catheter use and their management. BMJ Open Respir Res. 2016;3(1):e000123.
   PubMed Web of Science ®Google Scholar
• Mekhaiel E, Kashyap R, Mullon JJ, et al. Infections associated with tunnelled indwelling pleural catheters in patients undergoing chemotherapy. J Bronchology Interv Pulmonol. 2013 Oct;20(4):299–303.
   PubMedGoogle Scholar
• Morel A, Mishra E, Medley L, et al. Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion. Thorax. 2011 May;66(5):448–449.
   PubMed Web of Science ®Google Scholar
• Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. Jama. 2012 Jun 13;307(22):2383–2389.
   PubMed Web of Science ®Google Scholar
• Thomas R, Budgeon CA, Kuok YJ, et al. Catheter tract metastasis associated with indwelling pleural catheters. Chest. 2014 Sep;146(3):557–562.
   PubMed Web of Science ®Google Scholar
• Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995 Sep;108(3):754–758.
   PubMed Web of Science ®Google Scholar
• O’Rourke N, Garcia JC, Paul J, et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol. 2007 Jul;84(1):18–22.
   PubMed Web of Science ®Google Scholar
• Bydder S, Phillips M, Joseph DJ, et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer. 2004 Jul 5;91(1):9–10.
   PubMed Web of Science ®Google Scholar
• Clive AO, Taylor H, Dobson L, et al. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial. Lancet Oncol. 2016;17(8):1094–1104.
   PubMed Web of Science ®Google Scholar
• Wrightson JM, Fysh E, Maskell NA, et al. Risk reduction in pleural procedures: sonography, simulation and supervision. Curr Opin Pulm Med. 2010 Jul;16(4):340–350.
   PubMed Web of Science ®Google Scholar
• Wilshire CL, Louie BE, Aye RW, et al. Safety and efficacy of fibrinolytic therapy in restoring function of an obstructed tunneled pleural catheter. Ann Am Thorac Soc. 2015 Sep;12(9):1317–1322.
   PubMed Web of Science ®Google Scholar
• Vial MR, Ost DE, Eapen GA, et al. Intrapleural fibrinolytic therapy in patients with nondraining indwelling pleural catheters. J Bronchology Interv Pulmonol. 2016 Apr;23(2):98–105.
   PubMed Web of Science ®Google Scholar
• Thomas R, Piccolo F, Miller D, et al. Intrapleural fibrinolysis for the treatment of indwelling pleural catheter-related symptomatic loculations: a multicenter observational study. Chest. 2015 Sep;148(3):746–751.
   PubMed Web of Science ®Google Scholar
• Fysh ETH, Wrightson JM, Lee YCG, et al. Fractured indwelling pleural catheters. Chest. 2012 Apr;141(4):1090–1094.
   PubMed Web of Science ®Google Scholar
• Putnam JB Jr., Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999 Nov 15;86(10):1992–1999.
   PubMed Web of Science ®Google Scholar
• Maskell NA. Treatment options for malignant pleural effusions: patient preference does matter. Jama. 2012 Jun 13;307(22):2432–2433.
   PubMed Web of Science ®Google Scholar
• Demmy TL, Gu L, Burkhalter JE, et al. Optimal management of malignant pleural effusions (results of CALGB 30102). J Natl Compr Canc Netw. 2012;10(8):975–982.
   PubMed Web of Science ®Google Scholar
• Boshuizen RC, Vd Noort V, Burgers JA, et al. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). Lung Cancer. 2017;108:9–14.
   PubMed Web of Science ®Google Scholar
• Feller-Kopman DJ, Reddy CB, DeCamp MM, et al. Management of malignant pleural effusions. Off ATS/STS/STR Clin Pract Guideline. 2018;198(7):839–849.
   Google Scholar
• Wahidi MM, Reddy C, Yarmus L, et al. Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial. Am J Respir Crit Care Med. 2017;195(8):1050–1057.
   PubMed Web of Science ®Google Scholar
• Muruganandan S, Azzopardi M, Fitzgerald DB, et al. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. Lancet Respir Med. 2018;6(9):671–680.
   PubMed Web of Science ®Google Scholar
• Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017 Feb;36(1):11–48.
   PubMed Web of Science ®Google Scholar
• Kniese C, Diab K, Ghabril M, et al. Indwelling pleural catheters in hepatic hydrothorax: a single-center series of outcomes and complications. Chest. 2019 Feb;155(2):307–314.
   PubMed Web of Science ®Google Scholar
• Bhatnagar R, Keenan EK, Morley AJ, et al. Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med. 2018;378(14):1313–1322.
   PubMed Web of Science ®Google Scholar
• Tremblay A, Dumitriu S, Stather DR, et al. Use of a drug eluting pleural catheter for pleurodesis. Exp Lung Res. 2012 Nov;38(9–10):475–482.
   PubMed Web of Science ®Google Scholar
• Bhatnagar R, Zahan-Evans N, Kearney C, et al. A Novel drug-eluting indwelling pleural catheter for the management of malignant effusions. Am J Respir Crit Care Med. 2018;197(1):136–138.
   PubMed Web of Science ®Google Scholar
• Murthy P, Ekeke CN, Russell KL, et al. Making cold malignant pleural effusions hot: driving novel immunotherapies. Oncolmmunology. 2019 April 3;8(4):1–24.
   Google Scholar
• Du N, Li X, Li F, et al. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion. Oncol Rep. 2013;29(6):2332–2340.
   PubMed Web of Science ®Google Scholar
• Jones DR, Taylor MD, Petroni GR, et al. Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion [Clinical Trial, Phase I Research Support, N.I.H., Extramural]. J Thorac Oncol. 2010 Jan;5(1):75–81.
   PubMed Web of Science ®Google Scholar
• Islam A, Takita H. Malignant pleural effusion and advanced stage low-grade non-hodgkin’s lymphoma successfully treated with intrapleural instillation of rituximab. Blood. 2012;120(21):4891.
   Google Scholar
• Sterman DH, Recio A, Haas AR, et al. A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions. Mol ther. 2010 Apr;18(4):852–860.
   PubMed Web of Science ®Google Scholar
• Aggarwal C, Haas AR, Metzger S, et al. Phase I study of intrapleural gene-mediated cytotoxic immunotherapy in patients with malignant pleural effusion. Mol Ther. 2018;26(5):1198–1205.
   PubMed Web of Science ®Google Scholar
• Ren S, Terman DS, Bohach G, et al. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Chest. 2004;126(5):1529–1539.
   PubMed Web of Science ®Google Scholar